3 completed, 2 unknown. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Unknown 2 |
| Phase 3 | 1 | Unknown 1 |
Follow Glia, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study Pro-ocular™ Topical Gel, Placebo Topical Gel - Dry Eye Syndrome, Keratoconjunctivitis Sicca | Phase 2 | Unknown | PharmaDax Inc. | 80 | 2021-05-20 | 2021-05-14 |
| Safety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Disease Pro-ocular™ Topical Gel 1%, Placebo - Ocular Graft-versus-host Disease | Phase 2 / Phase 3 | Unknown | Glia, LLC | 44 | 2021-04-15 | 2023-03-24 |
| Treatment Safety and Efficacy of Pro-ocular™ 1% for Chronic Ocular Graft Following Allogeneic HSCT. Pro-ocular™ topical gel, Placebo topical gel - Chronic Ocular Graft-versus-host Disease | Phase 2 | Completed | Glia, LLC | 33 | 2019-10-17 | 2025-05-06 |
| Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel CLM2 topical gel, Placebo topical gel - Contact Lens Discomfort, Contact Lens-induced Corneal Disorder | Phase 2 | Completed | Glia, LLC | 30 | 2019-06-27 | 2023-03-24 |
| Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101 GL101, Placebo - Ocular Surface Disease | Phase 2 | Completed | Glia, LLC | 49 | 2016-01-22 | 2023-03-24 |
Dry Eye Syndromes (1) · Keratoconjunctivitis Sicca (1)
United States (4) · Taiwan (1)
Meng C. Lin, OD,PhD,FAAO (1) · Peichun Kuo (1) · Robert Ritch, MD (1) · Zhonghui K Luo, MD, PhD (1)